Catalyst Wire Dossier Catalyst Wire Dossier

VQW-765

· Vanda Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VQW-765, covering 2024-03-20 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder [Phase 3]

See pricing